GlassScriptPhysician profile
William Charles Etts
NPI 1326667700
$742.25
in general payments reported to CMS, 2019-2025
9 companies · $720 in 2025
The $720 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $22.74 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $246.95 | 2025 | Apligraf |
| Smith+Nephew, INC. | $179.75 | 2025 | Renasys Touch, Oasis |
| Integra Lifesciences Corporation | $130.98 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Treace Medical Concepts, INC. | $42.25 | 2025 | |
| Abbvie INC. | $33.02 | 2025 | |
| Aroa Biosurgery Incorporated | $31.46 | 2025 | |
| Stryker Corporation | $28.25 | 2025 | Prostep Mica |
| Tactile Systems Technology INC | $26.85 | 2025 | Flexitouch Plus, Nimbl |
| Polaris Technology Solutions LLC | $22.74 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Etts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.